Detecting amyloid–β pathology in subjective cognitive decline using plasma and CSF biomarkersResearch in context
Summary: Background: Subjective cognitive decline (SCD) may represent an early stage of Alzheimer’s disease (AD), but biomarker studies in this population are limited. Therefore, we compared the performance of a comprehensive panel of novel cerebrospinal fluid (CSF) and blood biomarkers across diff...
Zapisane w:
| Główni autorzy: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2026-07-01
|
| Seria: | EBioMedicine |
| Hasła przedmiotowe: | |
| Dostęp online: | http://www.sciencedirect.com/science/article/pii/S2352396426002148 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|
